After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Neumora Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Neumora Therapeutics Inc is $122.05M. A total of 1.35 million shares were traded on the day, compared to an average of 1.12M shares.
In the most recent transaction, Henry Gosebruch bought 15,000 shares of NMRA for 1.43 per share on Mar 12 ’25. In a previous transaction on Feb 18 ’25, BERNS PAUL L sold 13,871 shares at 1.69 per share. NMRA shares that the insider owns now total 7,405,004.
Among the insiders who sold shares, Milligan Michael Lee disposed of 1,978 shares on Feb 18 ’25 at a per-share price of $1.69. This resulted in the insider holding 22,470 shares of NMRA after the transaction. In another insider transaction, Aurora Daljit Singh sold 8,565 shares at $1.68 per share on Feb 18 ’25. Company shares held by the Chief Strategy Officer now total 88,935.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NMRA has a high of $17.19 and a low of $0.61.
As of this writing, NMRA has an earnings estimate of -$0.37 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.33 per share and a lower estimate of -$0.44.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NMRA’s latest balance sheet shows that the firm has $409.25M in Cash & Short Term Investments as of fiscal 2021. There were $2.05M in debt and $23.28M in liabilities at the time. Its Book Value Per Share was $1.41, while its Total Shareholder’s Equity was -$325.22M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
